Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma (Q47741041)
scientific article published in December 1998
Language:
Current Data About Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma
(P31) (Q13442814)
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P50) (Q89187648)
(P1545) 15
(P1932) R Champlin
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(Q66764444)
(P1545) 10
(P1932) S Giralt
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(Q116176461)
(P1545) 1
(P1932) I F Khouri
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P304) 3803-3809
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P407) (Q1860)

(P433) 12
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P478) 16
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P577) Tuesday, December 1, 1998
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P921) (Q422232)
(P887)

(Q65592366)
(P887)

(P1433) (Q400292)
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P1476) "Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma" (language: en)
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

(P2093) J Romaguera
(P1545) 2
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

H Kantarjian
(P1545) 3
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

J L Palmer
(P1545) 4
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

W C Pugh
(P1545) 5
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

M Korbling
(P1545) 6
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

F Hagemeister
(P1545) 7
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

B Samuels
(P1545) 8
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

A Rodriguez
(P1545) 9
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

A Younes
(P1545) 11
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

D Przepiorka
(P1545) 12
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

D Claxton
(P1545) 13
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

F Cabanillas
(P1545) 14
(P248)
(P698) 9850025
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9850025

other details
description scientific article published in December 1998

External Links
(P356) 10.1200/JCO.1998.16.12.3803
(P698) 9850025